Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.

Transoral Incisionless Fundoplication (TIF) Registry

Clinical Trial Details

This study is for men and women over 18 years of age who have suspected or known gastroesophageal reflux disease (GERD) or its associated complications, such as Barrett’s esophagus (a precancerous condition), or trouble swallowing due to esophagitis or scarring (stricture), who are undergoing diagnostic evaluation and treatment with Transoral Incisionless Fundoplication (TIF).  

The purpose of this registry study is to learn more about which treatments are effective for patients with different types of GERD symptoms. The registry will also collect relevant information about body weight, height, medications, medical history and other medical results.

If an individual agrees to be in this study, we will ask the following things for research purposes:

  • Complete the study questionnaires on or before their initial medical visit through a secure online web application called REDCap. If the subject prefers, they may complete the questionnaires on paper instead of online. The questionnaire will be completed at 6 months, and then annually after the initial physician visit or treatment procedure for 5 years.
  • Allow the information being collected as part of the medical care for GERD to be recorded in the Heartburn Center Registry through REDCap. The data in the registry may be used without any personal identifying information and shared with other collaborating researchers for other studies related to GERD.

   Compensation for completing the study questionnaires will be provided.

   Participation in this study will last up to 5 years.

Key Eligibility: 
  1. Men and women who are 18 years of age and older.
  2. Individuals who have suspected or known GERD.

  Detailed eligibility will be reviewed when individual’s contact the study team.

Study contact by location

Upper East Side - Manhattan


Andrea Herr, NP

Primary Investigator(s)

Protocol ID(s)

Weill Cornell Medicine IRB #:





Open to Enrollment

Age Group